Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy

The epidermal growth factor receptor (EGFR) is a validated target in squamous cell carcinoma (SCC) of the head and neck. Most patients, however, do not respond or develop resistance to this agent. Mammalian target of rapamycin (mTOR) is involved in the pathogenesis of SCC of the head and neck (SCCHN...

Descripción completa

Detalles Bibliográficos
Autores principales: Jimeno, A, Kulesza, P, Wheelhouse, J, Chan, A, Zhang, X, Kincaid, E, Chen, R, Clark, D P, Forastiere, A, Hidalgo, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360107/
https://www.ncbi.nlm.nih.gov/pubmed/17342092
http://dx.doi.org/10.1038/sj.bjc.6603656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360107/
https://www.ncbi.nlm.nih.gov/pubmed/17342092
http://dx.doi.org/10.1038/sj.bjc.6603656

Ejemplares similares